Aetion
Jonathan is the senior independent non-executive director of HSBC Holdings plc, chairman of HSBC Bank plc, and chairman of HSBC Holdings’ Group Audit Committee. He also sits on the Group Risk Committee.
Jonathan is also chairman of Proteus Digital Health and a non-executive director of Genomics England. Along with his wife, Sue, he is a trustee of the Jinja Educational Trust, which aims to improve the education, training, and welfare of young people in Uganda. Jonathan was CFO of Novartis AG from 2009 to 2013. Prior to joining Novartis, Jonathan was a partner and managing director of Goldman Sachs, CFO of AstraZeneca plc, and a partner of KPMG. Jonathan’s governance experience includes serving as a non-executive director and chair of the audit committees of Diageo plc and Qinetiq plc.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.